Immunosuppressive therapy in the treatment of autoimmune diseases.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy; D000741:Anemia, Aplastic / Q000188:drug therapy; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000628:therapy*; D001379:Azathioprine / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D003613:Danazol / Q000627:therapeutic use; D005260:Female; D006521:Hepatitis, Chronic / Q000188:drug therapy; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy; D011247:Pregnancy
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007978:Levamisole; D015122:Mercaptopurine; D001379:Azathioprine; D003613:Danazol; D003078:Colchicine; D008727:Methotrexate